GHUCCTS

News

Share This
  • Nov 15, 2019

GHUCCTS KL2 Program Now Accepting Applications for 2019-2020 Cycle

The GHUCCTS KL2 Program is now accepting applications for the 2019-2020 cycle. The pre-application deadline is extended to Friday December 31, 2019. The final application is due on Wednesday February 19, 2020 at 11:59 PM EST.

For more information, visit our KL2 Scholars Program page. Online informational sessions are available on :

  • Friday November 22 at 2 PM
  • Monday November 25 at 5:30 PM
  • Monday December 2 at 3 PM
  • Wednesday December 4 at 2 PM

To register, please email ghucctseducation@georgetown.edu

Download Flyer | Download RFA | KL2 Scholars Program

Related News

Funding Opportunity: ACCOuNT TCC now accepting pilot grant applications

Jan 22, 2020

The African American Pharmacogenomic Consortium Network Transdisciplinary Collaborative Center (ACCOuNT TCC) – a partnership between ITM investigators and Northwestern University – is offering a Pilot Grant Program to stimulate community stakeholders to be the principal drivers of pharmacogenomics-enabling research projects that they conceive, plan, and execute with support from research collaborators.

Register Today: GHUCCTS Responsible Conduct of Research Training

Jan 17, 2020

GHUCCTS is offering face-to-face training for predoctoral students, postdoctoral fellows and early career investigators in the responsible conduct of research in order to promote ethical, rigorous and reproducible science. The series dovetails to required CITI modules and provides an opportunity for investigators to discuss all aspects of these topics with an expert in the field. This series also fulfills the requirements of multiple funding agencies.

Funding Opportunity: TIN HEAL Initiative: Pain Management Multisite Effectiveness Research Network (ERN)

Jan 16, 2020

The National Institute of Health (NIH) Helping to End Addiction Long-term (HEAL) initiative aims to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative will bolster research across NIH to (1) improve treatment for opioid misuse and addiction and (2) enhance pain management.

Close